Delivery Order SPE2DB22D3010-SPE2DB25FP3PG
- Not listed
- The Defense Logistics Agency awarded a $4,476.48 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, with an ultimate completion date of September 3, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $15,400.75 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under a larger contract vehicle. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $41,926.99 firm fixed price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls pharmaceutical supply. This non-competitive delivery order, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a child contract under AmerisourceBergen's larger federal pharmaceutical supply vehicle. The product will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp received a $12,823.56 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 3, 2025, for HUMIRA (CF) Pen 40 mg/0.4 mls pharmaceutical products, with completion targeted for September 4, 2025. This non-set-aside contract will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a competitive award to the established pharmaceutical distributor, which maintains significant federal...
- The Defense Logistics Agency awarded a $63,341.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical supplies. The contract was competitively awarded without set-aside provisions and is scheduled for completion by September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $19,051.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. The award, issued on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a $1,556.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used to treat inflammatory conditions. This non-set-aside contract was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $14,388.29 to AmerisourceBergen Drug Corp for HUMIRA(CF) Pen 40 mg/0.4 mL on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a non-competitive procurement using the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The pharmaceutical product will be...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,021.20 on August 13, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL. This is a firm fixed-price, non-set-aside competitive award with a performance location in Conshohocken, Pennsylvania, and an ultimate completion date of August 14, 2025. The delivery order represents a single transaction under AmerisourceBergen's larger federal contract vehicle with the Defense Logistics Agency. This delivery...
- The Defense Logistics Agency awarded a $3,776.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, with an ultimate completion date of July 23, 2025. This competitive award, issued on July 22, 2025, carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The performance...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP3PGDelivery Order
The Defense Logistics Agency awarded a $14,127.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, with an ultimate completion date of September 23, 2025. This is a non-set-aside contract issued to the Corporate Office division of the company, headquartered in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical procurement under AmerisourceBergen's larger federal contract portfolio with the Defense Logistics Agency's Medical Supply Chain. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. That prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company's federal contracting demonstrates consistent capability to meet competitive procurement requirements across multiple therapeutic domains, serving customers including the Defense Health Agency and the U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.1k | 9/22/25 |